Navigation Links
PharmAthene Reports First Quarter 2011 Financial and Operating Results

ed; 46,322,026 and 46,238,244 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively4,6324,624Additional paid-in-capital201,570,845200,847,468Accumulated other comprehensive income1,227,4341,250,497Accumulated deficit(191,967,541)(189,891,884)Total stockholders'  equity10,835,37012,210,705Total liabilities and stockholders' equity






3,116,553Operating expenses:Research and development5,820,3744,952,393General and administrative4,939,6545,325,422Depreciation and amortization117,629245,258Total operating expenses10,877,65710,523,073Loss from operations(4,539,935)(7,406,520)Other income (expense):Interest income3,1543,483Interest expense(15,435)(948,150)Other income (expense)(11,906)139,422Change in market value of derivative instruments2,488,465267,496Total other income (expense)2,464,278(537,749)Net loss



(7,944,269)Basic and diluted net loss per share



(0.28)Weighted average shares used in calculation of basic and diluted net loss per share46,276,87428,172,802

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene to Host Year-End 2010 Earnings Conference Call and Webcast on Monday, March 28, 2011
2. PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
3. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
4. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
5. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
6. PharmAthene Announces Pricing of $15 Million Public Offering
7. PharmAthene Announces Proposed Common Stock Offering
8. PharmAthene Announces $3.9 Million Registered Direct Offering
9. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
10. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
11. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
Post Your Comments:
(Date:10/9/2015)... ... 09, 2015 , ... Leading microbial genomics startup uBiome today launched the first-ever ... between weight management and the microbiome. The study uses the ResearchKit framework, designed by ... app. , The uBiome app is available as a free download from the App ...
(Date:10/8/2015)... -- Genetic testing for mutations beyond those currently recommended in ... at risk of having a child with cystic fibrosis, ... American Society of Human Genetics (ASHG) Annual Meeting, which ... . The study is one of four that ... presenting at the conference this week demonstrating the clinical ...
(Date:10/8/2015)... 8, 2015 . ... --> Goldman Small Cap Research, a stock ... and microcap sectors, announced today that it has ... Biotech, Inc. (OTCQB - PMCB), a publicly traded, ... preparing treatments for cancer and diabetes. To view ...
(Date:10/8/2015)... ALS Association, in partnership with Prize4Life, is pleased to ... technology solutions for people living with ALS. ... sclerosis) is a progressive neurodegenerative disease that affects neurons ... Eventually, people with ALS lose the ability to initiate ... paralysis and death within two to five years of ...
Breaking Biology Technology:
... (NASDAQ: ITMN ) today announced that Dan Welch, ... at the Bank of America Merrill Lynch 2011 Health Care ... 1:00 p.m. PDT.   To access a live ... may log on to the investor relations page of InterMune,s ...
... NxStage Medical, Inc. (Nasdaq: NXTM ), ... financial results for the first quarter of 2011 ended ... end of its guidance range. (Logo: ... increased 25 percent to a record $50.6 million compared ...
... Md. It took nearly a decade before University of ... the anthrax strain used in the 2001 deadly letter attacks. ... high-powered science team have published the first account of the ... and gave bioterrorism investigators a way to "fingerprint" bacteria. ...
Cached Biology Technology:
(Date:9/10/2015)... This report provides detailed descriptions of the ... emerging sensor types that will dominate in the future. ... the wearable technology hype curve in the last five ... feature with all of them is the prominence of ... useful functions. Sensors collect data about the physical and ...
(Date:9/10/2015)... 2015 Report Details The global ... upon previous expectations of revenues, consumer adoption and even ... in which wearables begin to achieve that mass market ... main reasons is the entrance of Apple to the ... market, but the overall size of the wearable technology ...
(Date:9/10/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... mobile commerce market, announces that the San ... will feature the Wocket® smart wallet for the first ... Touch Of Modern is an online retailer ... its 7.2 million members. Customers are affluent, urban influencers ...
Breaking Biology News(10 mins):
... can play in helping the UK meet its targets ... green economy have been highlighted today with the publication ... These three new analyses, Technology Innovation Needs Assessments (TINAs), ... and are part of a series that spans 11 ...
... of Texas at Arlington physics professor has helped create ... light and thermal energy into electrical current, surpassing earlier ... not both. , Working with Louisiana Tech University ... Wei Chen and graduate students Santana Bala Lakshmanan and ...
... a team at McGill University, have discovered a new ... endocrine disorder is typically caused by problems of the ... brain or the pituitary gland (hypophysis). However, a new ... unsuspected source and is reported in the journal ...
Cached Biology News:
Prepared with distilled water. Yeast extract solution is autolyzed at 150 g/L....
Streptomycin sulfate an aminoglycoside used for bacterial selection binds to the small ribosomal subunit and interferes with protein biosynthesis.21H39N7O12)2x3H2SO4Formula weight:...
The BD OptEIA Rat TNF-alpha ELISA Kit is for the quantitative determination of TNF-alpha in rat serum, plasma and cell culture supernatant....
Biology Products: